Cargando…
Infracentimetric HER-2 positive breast tumours—review of the literature
Breast cancer is the most common malignant neoplasm in the world among women. As a result of the dissemination of population screening programmes, about half of non-metastatic breast cancers are now diagnosed at stage I. 10–15% of T1abN0 tumours over-express human epidermal growth factor (HER-2). Th...
Autores principales: | da Fonseca Reis Silva, Danilo, Ribeiro, Joana M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cancer Intelligence
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4659705/ https://www.ncbi.nlm.nih.gov/pubmed/26635897 http://dx.doi.org/10.3332/ecancer.2015.593 |
Ejemplares similares
-
Appraisal of Systemic Treatment Strategies in Early HER2-Positive Breast Cancer—A Literature Review
por: Giffoni de Mello Morais Mata, Danilo, et al.
Publicado: (2023) -
Appraising Adjuvant Endocrine Therapy in Hormone Receptor Positive HER2-Negative Breast Cancer—A Literature Review
por: Mata, Danilo Giffoni de Mello Morais, et al.
Publicado: (2022) -
Molecular vulnerabilities and therapeutic resistance in hormone receptor positive and HER2 dependent breast cancer tumours
por: Velaga, Ravi, et al.
Publicado: (2022) -
HER2 expression in breast cancer primary tumours and corresponding metastases. Original data and literature review
por: Carlsson, J, et al.
Publicado: (2004) -
A positive role for PEA3 in HER2-mediated breast tumour progression
por: Myers, E, et al.
Publicado: (2006)